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Many deductions concerning the spread of mumps virus were made from 
clinical and epidemiologic observations before confirmation by laboratory tests 
was possible.  The evidence presented by various authors in regard  to  this 
subject has been critically reviewed by Gordon (1).  The following conclusions 
appeared justified on epidemiologic grounds: (a)  The average incubation period 
of typical mumps was shown to be 18 days.  The disease was found to become 
communicable about 48 hours prior to the onset of glandular enlargement and 
the period of communicability to last for several days following the appearance 
of signs of illness.  (b)  Cases  of unusual manifestations of mumps,  such as 
primary meningoencephalitis or primary orchitis in the absence of recognized 
involvement of the salivary glands, could be properly classified only if they 
occurred in institutions or families where typical mumps was prevalent.  It 
was shown, on occasion, that these patients were able to transmit mumps to 
contacts, possibly because of the presence of virus in their saliva at some stage 
of the infection.  (c)  Inapparent infections with mumps virus were thought to 
be frequent, since in spite of the prevalence of the disease only about 60 per cent 
of the adult population of the United States had suffered clinical attacks.  It 
was also inferred that such inapparent cases of infection might spread the virus 
to susceptible individuals, thus maintaining the chain of infection in an epi- 
demic. 
With the development of laboratory tests for the diagnosis of infections with 
mumps virus (2, 3) and of technics for the isolation of the agent in chick embryos 
(4, 5), it has become possible to confirm many of the earlier observations by 
more  direct  proof.  Thus,  the  existence  of  inapparent  infections and  their 
relative  frequency  has  been  demonstrated  by  application  of  complement 
fixation tests (2, 6,  7).  By the same means, the diagnosis of unusual mani- 
festations of mumps  has  become  a  routine matter  (8,  3).  Virus  has  been 
isolated from  the saliva of cases of parotitis as late as 6 days after onset of 
disease (9).  It has also been demonstrated in the spinal fluid of patients with 
meningoencephalitis without salivary gland involvement (10, 11). 
* These studies were supported by a  grant-in-aid from the United States Public Health 
Service. 
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The present paper is concerned with the isolation of mumps virus from the 
saliva  of  human beings at  various  stages  of  infection.  It  was  considered 
difficult to approach these problems under epidemic conditions since frequently 
the time and intensity of exposure would not be accurately known, whereas the 
study of Cases experimentally exposed to mumps virus offered the advantage of 
controlling both these factors.  The results obtained under such experimental 
conditions afford evidence that the period of infectivity of cases with involve- 
ment of the salivary glands may begin as early as 6 days prior to onset of recog- 
nizable glandular swelling, and may last for more than one week.  It will also 
be  shown  that  a  patient with  orchitis  without  salivary gland involvement 
harbored mumps virus in his saliva at some time prior to the development of 
symptoms.  Finally, it will be demonstrated that cases of inapparent infection 
may excrete virus in saliva for considerable periods of time and that they may 
be responsible for spreading the disease in an epidemic. 
Methods and Materials 
Selection of Susceptible Subjects.--Insfitutionaiized  children in good physical condition and 
without known  histories of mumps were bled and their sera tested for antibodies against mumps 
complement fixation antigens.  Those children whose sera failed to react with the soluble and 
the virus antigens (12) were considered susceptible to mumps and, therefore, chosen for these 
experiments with the permission of parents and guardians. 
Virus.--Two strains of mumps virus (F and B) were used.  They had been isolated from 
the saliva of cases of parofitis  by amniotic inoculation of chick embryos  (13).  Amniotic 
fluid of the fifth passage was quick frozen and stored in glass-sealed  ampules in a dry-ice cabinet 
until used.  The preparations of both strains contained 107 50 per cent infectivity doses for 
chick embryos per ml. and 5000 (F) and 7500 (B) hemagglutinating units. 
lsoletion of Virus fro  mSa/iva.-Saliva or mouth washings were obtained in the first experi- 
ment, depending on the ability of the children to furnish saliva.  In the second experiment 
saliva was mechanically aspirated by means of a device consisting of a thin bent copper tube 
leading into a glass trap which was in turn connected with an electrically driven suction pump. 
Individual  equipment was used for each child.  The specimens were immediately transferred 
into ampules which were sealed off in an oxygen flame.  Mter quick freezing the ampules 
were transported  to the laboratory  packed in dry-ice.  They were stored at  -70°C. until 
inoculation of chick embryos was possible. 
Before injection the specimens were thawed and centrifuged at 2000 R.P.~. for I0 minutes. 
The supernatant fluids were incubated at 37°C. for 1 hour with penicillin and streptomycin, 
using i000 units of each per ml.  The specimens were injected in 0.2 ml. amounts into the 
amniofic cavity of ten 8-day-old chick embryos, under direct observation as described previ- 
ously (12).  Mter further incubation  for 5 days at 36-37°C. the eggs were chilled for 1 to 3 
hours at 4°C. and the amniotic fluids were harvested aseptically.  These were tested  indi- 
vidually on slides for their ability to agglutinate chicken red cells.  Further transfers were 
made by injecting undiluted amuiotic fluids into new groups of eggs.  A specimen of saliva 
was considered negative if three amniotic passages failed to indicate the presence of virus. 
For the identification of the isolated strains of virus pools of amniotic fluids of the respective 
groups of eggs were used as antigens for complement fixation tests with known acute and 
convalescent sera of patients with mumps.  In all cases tested the agent isolated was identified 
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Serolog~ T~.--Blood was drawn from all individuals at intervals to study the develop- 
ment of complement-fixing  antibodies.  The technics and the antigens employed have been 
fully described  in previous communications (3, 12). 
EXPERIMENTAL 
Two experiments were conducted with a  total of 15 children.  The experi- 
ments differed in regard to the amount of virus to which the subjects were 
exposed and the method by which it was applied.  In all other respects the two 
tests were essentially alike.  Before  ~  exposure to the virus the children were 
isolated in a hospital ward where they remained for the period of observation, 
under  the  care  of trained  nurses.  Their temperatures were recorded twice 
daily, and 4  times daily in cases in which fever was observed.  Beginning 2 
weeks after exposure the children were examined daily for signs and symptoms 
of disease by one of the  authors,  except for a  few occasions when adverse 
weather conditions rendered the institution inaccessible. 
Experim~t 1  (November,  1947).--Seven children were exposed  to active mumps  virus 
which was deposited by means of a coarse spray on the mucous membrane of the oral cavity, 
particularly close to the orifices of Stensen's duct.  Four of the children received 2.0 mL of 
amniotic fluid containing strain F, and three children were infected with the same amount of 
strain B.  The amount of virus sprayed for each child corresponded to 2 X  107 IDs0 for chick 
embryos in the case of both strains. 
Experim~t 2 (January, 1948).--In the second experiment, eight subjects were exposed to 
finely dispersed  virus,  by means of an atomizer,  1 operated by compressed air.  Thus  the 
children inhaled small droplets and droplet nuclei through their mouths.  A mixture of equal 
parts of strains F  and B was employed.  Four of the subjects were exposed to a spray of 1.0 
ml. of a  1 : 100 dilution of infected amniotic fluid, containing 105 IDs0 for chick embryos, and 
the remaining children inhaled 1.0 ml. of undiinted fluid containing 107 IDs0. 
Since the clinical observations  and the laboratory findings of the two experiments were 
similar, they will be discussed together.  A summary of all the data is presented in Figs.  1 
and 2. 
Clinical Observations.--As can be seen from the figures," four of the fifteen 
children came down with a clinically well defined parotitis (cases 2, 7, 11, and 
12).  Two additional cases (Nos. 1 and 5) showed signs of involvement of the 
submaxillary glands.  Case 6 developed orchitis without parotitis.  One case 
(No.  15) came down with tonsillitis and palpable lymph nodes 17 days after 
exposure to mumps virus.  The purulent exudate and the high temperature 
suggested an intercurrent bacterial infection, which was promptly relieved by 
chemotherapy.  The additional seven children (cases 3,4, 8, 9, 10, 13, and 14) 
remained well during  the period of observation except for minor febrile re- 
sponses.  The significance of these elevations of temperature is questionable. 
The incubation periods fell into the range encountered in the epidemic dis- 
ease.  The first case of parotitis (No. 7) was observed on the 14th day after 
1 Kindly supplied by the Vaponefrin Company, Upper Darby, Pennsylvania. 226  ISOLATION  OF MUMPS  VIRUS 
exposure; the remaining three subjects showed signs of parotid swelling on the 
15th,  16th, and 19th day after infection (cases 11,  12, and 2).  Submaxillary 
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I~G. 1.  Experiment 1.  Summary of results 
involvement was noted on the  17th and 20th day in cases 1 and 5.  Case 6 
developed orchitis on the 25th day after spraying of the virus. 
The clinical course in all patients with involvement of the salivary glands 
was mild and the swellings subsided within 4 to 5 days.  The orchids affected 
only one of the testicles.  This case, likewise, was very mild and lasted for 4 
days.  It responded to conservative treatment and the pain was rapidly re- 
lieved by analgesics.  The general mildness  of the  illnesses produced  is  re- 
flected in the moderate febrile responses recorded in Figs.  1 and 2. G.  B~NLE,  W.  ]IEI~  K.  K.  WENDELL,  AND  P.  ROSENBERG  227 
Serologic  Results.--Complement  fixation tests were performed with sera taken 
from all children at intervals during the course of the experiments.  All cases 
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Fzo,  2.  Experiment  2.  Summary  of  results 
who showed signs of infection developed antibodies to the soluble (S) as well as 
to the virus (V)  antigen in a  manner described for the epidemic disease  (3). 
The antibodies to the soluble antigen commenced to rise in less than 2 weeks 
after exposure.  Some of the cases showed also appreciable titers to the virus 
antigen at that date (cases 7, 11, and 12).  Thus, both anti-V and anti-S anti- 
bodies had reached high levels before signs of disease were noted.  All cases 
showed further increases in antibodies in the following 2 weeks. 228  ISOLATION  O1  e  MUMPS  VIRUS 
The eight children who failed to exhibit signs of mumps showed antibody 
responses similar to those of the children who developed clinical illness.  These 
cases must be classified, then, as inapparent infections.  The rate of antibody 
formation against the V antigen was somewhat delayed in three of the children 
(cases 5,  13, and 15). 
Isolation  of Virus.--Series of specimens of saliva were thus available from (a) 
six patients  with involvement  of the salivary  glands;  (b)  one patient with a 
manifestation  of mumps  without  salivary  gland  involvement  (orchitis);  and 
(c) eight subjects who were classified as having inapparent infections according 
to their serological response.  This group includes the patient with tonsillitis. 
•  VIRUS I~DLRTED  ] 
~SOIGL~ION  O~ V~r~x3  I~OTI~  CO.5@80~  o  NO VIRUS tSOLRTEO 
I 
P,  pparen'~  and  Ina!op~re~'¢  I~Fection  x  SPECIMEN LOST 
"~OHSI.IT OF OISERSE 
~7IRU5  --~a~s  ~P~¢r Exposure-- 
ease  ID  -  I C't~.Nt  oo.'~ 
S'¢r'ctin  :~l  S~.dn$  8  :lO  lZ  1.  16  18  ~.o  ~.?.  *~4 
no.__.  __  ~'I  ......  --l--4--l--+--l~l--+-l-+-l--~--I--l--I--+-l--~- 
~  10  '3 ]PRROTITIS  O~-e  ~-~-o-e--x  O-O 
1~  "  I  "  "  o-----o  o-e-o-o-e--l---o-o 
=  .  mso  I  .  o  o-~-o+~-~  o 
1  r  C  .*  ~-O-~-e----~---O 
5  B  ..  .  o  o-e-o-.~-o  o 
6  ~  .  ORCHITIS  O  O--@--e--C---O  O  4" 
O  3 
8 
10 
13 
15 
4 
9 
T+B 
or 
a~ 
B 
F *I~ 
109'0 
105"O 
107"3 
107'0 
HO~E 
it 
H 
N 
R 
N 
n 
o-q~-o-O-o 
~o-e-o-e--e 
0  O-O-O-O--I--O 
O----O--O-O--I-  0 - e----- • 
o--o-o-e-o--o 
OIO~4--H--O 
0--0--0--0--0 
0--0--0--0--0--0--0--0 
FIG. 3 
Figs. 1 and 2 show the attempts and successful isolations obtained from each 
of the subjects in relation to clinical and serological findings.  Fig. 3 summa- 
rizes the result of the isolation procedures, grouped according to the clinical 
signs of infection seen in the children.  The positive findings require no com- 
ment.  The negative data, on the other hand, do not necessarily indicate that 
no virus was excreted on the day the specimen was obtained.  As can be seen, 
negative results were recorded in some instances in which the specimens of the 
preceding and following days were positive.  It is possible that the technic of 
sampling of the saliva was inadequate or that the excretion of virus occurred 
intermittently.  The collection of specimens was unfortunately less regular in 
the later days of the two experiments because of snow storms, which prevented 
traveling to the institution on several occasions.  Attempts to isolate virus on 
the 1st and 2nd days after exposure failed.  Later in the experimental period, 
as can be seen in Fig. 3, all children who showed clinical signs of parotitis or of G.  ttENLE,  W.  HENLE,  K.  K.  WENDELL,  AND  P.  ROSENBERG  229 
submaxillary swelling excreted virus for several days.  In all these cases, virus 
was isolated 2 to 6 days'prior to the appearance of swelling, beginning at the 
11th to 15th day after spraying.  Virus was also demonstrated in some of the 
samples of saliva taken after onset of the disease.  Thus in case 7 virus was 
still present on the 4th day of illness. 
Isolation of virus was not only successful in the cases just described but also 
from the saliva  of the  case of orchitis,  who showed no involvement of the 
salivary glands.  Virus was found on the 15th and 16th days after exposure to 
mumps virus, i.e.,  10 and 9 days prior to the onset of orchitis.  In addition, 
virus was isolated from the saliva of six of the eight children who experienced 
TABLE I 
Isolation of Virus from the Saliva of Representative Cases 
Case 
No. 
12 
Pas- 
sage 
No. 
0/8* 
o/s 
0/8 
0/8 
0/7 
O/8 
Time after exposure, days 
13 
o/6 
o/6 
0/4 
0/9 
0/8 
8/8 
0/6 
1/5 
0/6 
15  16 
3/5  0/8 
5/6  0/6 
0/6 
0/6  0/6 
0/7  s/6 
0/7 
17 
3/6 
6/7 
I 
1  20 
8/8 
0/3  0/6 
0/6  i0/7 
o/8 i o/8 
22 
o/8 
o/7 
o/5 
0/8 
0/8 
Period of 
excretion 
24 
days 
At  least  5 
3-4 
Bold-faced type is used to emphasize the positive isolations. 
* None  of eight eggs showed  positive hemagglutination  on  5th  day  after  inoculation. 
Two of the ten originally injected embryos died of non-specific causes during the incubation 
period. 
All embryos died on account of bacterial contamination. 
inapparent infections (cases 3, 8, 10, 13, 14, and 15) at about the same time as 
from the clinical cases of mumps.  As shown, virus was isolated from these 
children for periods of 1 to 9 days.  Only children 4 and 9 failed to reveal virus 
in any of the available specimens. 
These data show then that virus could be isolated from thirteen out of fifteen 
children  exposed  to  mumps  virus  under  experimental conditions.  Table  I 
gives the results of the isolation of virus in two of the children.  As can be 
seen, some of the specimens of saliva yielded, on first passage in the majority 
of the injected eggs, sufficient concentrations of virus to cause hemagglutina- 
tion.  With other samples two, or in one instance even three, passages were 
required before positive results were obtained.  A  specimen which failed to 
yield hemagglutination by the third passage was considered free of virus.  The 
allantoic fluids of these eggs never showed hemagglutinating properties.  The 230  ISOLATION  0]~  MUMPS  VIRUS 
death rate in chick embryos inoculated with bacteriologically sterile saliva was 
frequently high.  In other instances the antibiotic failed to inhibit bacterial 
multiplication and a  few entire groups of eggs were lost because of such con- 
tamination. 
DISCUSSION 
It is obvious that no quantitative and  statistically valid conclusions can be 
drawn from the data presented, since these were derived from only a  small 
number of cases of induced infection with mumps virus.  However, the data 
confirm  experimentally  some  of  the  earlier  conclusions  deduced  from  epi- 
demiologic observations (1).  Thus, the incidence of inapparent infections in 
mumps has been estimated to be of the order of 30 to 40 per cent.  Serological 
analysis of epidemics in recent years has confirmed this contention in that a 
high percentage of exposed subjects developed complement-fixing antibodies 
for mumps in the absence of clinical signs of infection (2, 6,  7).  The experi- 
mental exposure leads to similar results.  In the present series,  eight of the 
fifteen exposed children must be classified as having had inapparent infections. 
The period of communicability of the experimental cases showing involve- 
ment of the salivary glands began, according to the results of isolation of virus, 
on the llth to the 15th day after exposure and extended to the 18th to 19th day. 
Thus, virus  appeared  in  the  saliva  2 to 6  days  prior  to  the  appearance  of 
glandular swelling, and it was found as late as 4 days after onset of the clinical 
signs.  Leymaster and  Ward  (9)  obtained virus  from one case  of epidemic 
mumps on the 6th day of disease.  It is possible that the experimental results 
are strongly influenced by the intensity of exposure.  A smaller dose of virus 
(< 1@ ID 50) might conceivably delay the onset of viral excretion for a few days, 
as well as prolong the incubation period. 
Most of the children who failed to show clinical signs of involvement of the 
salivary glands nevertheless excreted virus in their saliva at certain times after 
exposure.  One  of  these  developed orchitis  at  a  later  stage.  It  had  been 
shown in the past on epidemiological grounds that such cases of unusual mani- 
festations  of mumps,  including  meningoencephalitis  without  parotitis,  may 
spread the infections to susceptible individuals (14, 15). 
The isolation of virus from the cases of inapparent infection was successful 
over a period of from 15 to 24 days after exposure.  They became "transitory 
carriers" for from 1 to 9 days or longer.  Unfortunately, no specimens of saliva 
were collected after the 24th day.  However, there are strong indications that 
one of the children of the second experiment, classified as having inapparent 
infection, was still harboring the virus on the 30th day after exposure, when the 
group were released from the hospital and returned to their cottage.  Between 
15 and 18 days thereafter, four cases of parotitis occurred in that cottage in 
children not belonging to the group.  Although there is no definite proof that G.  HENLE,  W.  HENLE,  K.  K.  WENDELL,  AND  P.  ROSENBERG  231 
the virus was derived from one of the returning children, the possibility cannot 
be denied, because of the time relationships encountered.  Whether the virus, 
if introduced by one of the children, was spread through the saliva, or whether 
it was present on contaminated clothing cannot be determined in  this case. 
However, transmission by contaminated apparel has generally been disregarded 
as a source of infection (1). 
It appears,  then, that the virus used for experimental exposure closely re- 
sembled the epidemic agent and had not become attenuated to any large extent 
as a result of five passages in the chick embryo.  The data, in addition, seem 
in  good  agreement  with  the  earlier  epidemiologic observations.  However, 
certain differences were noted in the rate of production of antibodies in the 
experimentally  exposed  subjects  in  comparison  with  cases  observed  under 
epidemic conditions.  In the natural disease antibodies to the soluble antigen 
may be present at the onset of swelling, or they rise very shortly thereafter; 
antibodies to the virus antigen usually appear in measurable quantities several 
days later, when antibodies to the soluble antigen have reached high levels. 
Only in the case of complications, such as orchitis, may high  titers to both 
antigens be found at the time of their onset.  On the other hand, in the experi- 
mental groups, distinct antibody levels for both antigens were found in the cases 
with involvement of the salivary glands, several days before clinical signs of the 
disease, with the exception of one patient who showed a low titer with the virus 
antigen at the time of the submaxillary swelling.  The patient with orchitis had 
high antibody levels 10 days before he showed signs of illness,  and subsequently 
a second rise in antibodies to both antigens was found.  It is possible that the 
findings described are the result of the rather intensive exposure under experi- 
mental conditions since most of the children were sprayed with l0  T IDs0 (for 
chick embryos).  When the dose was decreased to 1@ IDs0 the antibodies to 
the V  antigen appeared at a  slower rate in two of the three cases who were 
classified as inapparent infections (cases 13 and 15). 
There does not seem to be a relationship between the development of comple- 
ment-fixing antibodies and the excretion of virus in saliva in the cases described. 
With the exception of case 3, whose antibody levels were the lowest in the two 
groups, antibody titers to the soluble antigen were high and, in some  cases 
antibodies to the virus antigen were measurable in large amounts when virus 
was isolated from the saliva.  The relationship between complement-fixing and 
neutralizing antibodies has not been fully established.  However, preliminary 
experiments with sera of some of the cases revealed that neutralizing antibodies 
were circulating in the blood stream at a  time when virus was found in the 
saliva.  It seems possible that after the virus has invaded the salivary glands 
it is no longer accessible to humoral antibodies unless they reach such high con- 
centrations in the blood as to be reflected in the secretions.  Such a situation 
would not be unlike that observed in the case of infections of man with influenza 
virus.  These questions will be the subject of further studies. 232  ISOLATION  OF  MU~IPS  VIRUS 
SU~rMARY 
Exposure of fifteen children to mumps virus of fifth amniotic passage  in 
chick embryos led to involvement of the salivary glands in six, orchitis in the 
absence of other manifestations of mumps in one, and to no signs of illness in 
eight.  Attempts to isolate virus from the saliva of these individuals gave the 
following results: 
1.  All  patients  with  involvement  of  the  salivary  glands  excreted  virus 
beginning on the llth to 15th day after exposure, 2 to 6 days prior to onset of 
clinical signs of disease and extending up to the 4th day of illness. 
2.  The patient with primary orchitis without any recognized involvement of 
the salivary glands excreted virus for 2 days, beginning on the 15th day after 
exposure and 10 days prior to his illness. 
3.  Six of the eight children classified as having inapparent infections because 
of their serologic response in the absence of clinical signs of illness,  began to 
excrete virus on the 15th to 16th day after exposure for from 1 to 9 or more 
days. 
The epid.emiologic significance of these data is discussed. 
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